Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

This publication has 19 references indexed in Scilit:

• Endocrinology: Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview
  Human Reproduction, 1995
• Fertilization and early embryology: Controlled comparison of Earle's balanced salt solution with Ménézo B2 medium for human in-vitro fertilization performance
  Human Reproduction, 1994
• A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge
  Fertility and Sterility, 1994
• The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program
  Fertility and Sterility, 1994
• Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation
  Human Reproduction, 1994
• High fertilization and implantation rates after intracytoplasmic sperm injection
  Human Reproduction, 1993
• The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women
  American Journal of Obstetrics and Gynecology, 1991
• Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation
  Fertility and Sterility, 1991
• The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT
  Human Reproduction, 1988
• Management of failed cycles in an IVF/GIFT programme with the combination of GnRH analogue and HMG
  Human Reproduction, 1987